Stock Movers cover image

Enagas Soars, AstraZeneca Gains, Pernod Ricard Rises

Stock Movers

00:00

AstraZeneca's COPD drug breakthrough

Tiwa outlines trial results showing reduced COPD flare-ups and $866m sales potential by 2032, with caution on data details.

Play episode from 01:38
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app